Quick Answer
CRESCENT BIOPHARMA, INC. reported Stockholders Equity of $203.01 million for fiscal year 2025.
CRESCENT BIOPHARMA, INC. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $203.01M | +1411.5% |
| 2024 | -$15.48M | — |
| 2024 | $0.00 | -100.0% |
| 2023 | $38.41M | -10.5% |
| 2022 | $42.93M | -47.4% |
| 2021 | $81.60M | -36.4% |
| 2020 | $128.22M | -16.8% |
| 2019 | $154.20M | -25.0% |
| 2018 | $205.46M | +71.6% |
| 2017 | $119.70M | +239.1% |
| 2016 | $35.30M | -12.8% |
| 2015 | $40.47M | -20.3% |
| 2014 | $50.80M | +1647.4% |
| 2013 | $2.91M | -76.8% |
| 2012 | $12.53M | +48.1% |
| 2011 | $8.46M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $116.64M | +9058.6% | -16.2% |
| June 30, 2025 | $139.25M | +594.1% | +561.7% |
| March 31, 2025 | -$30.16M | -204.3% | -94.9% |
| December 31, 2024 | -$15.48M | -140.3% | -1088.9% |
| September 30, 2024 | -$1.30M | -102.8% | -106.5% |
| June 30, 2024 | $20.06M | -63.4% | -30.6% |
| March 31, 2024 | $28.91M | -53.5% | -24.7% |
| December 31, 2023 | $38.41M | -10.5% | -17.5% |
- CRESCENT BIOPHARMA, INC. showed an increase of +1411.5% in Stockholders Equity compared to the prior fiscal year.
- Over the 2011–2025 period, CRESCENT BIOPHARMA, INC.’s stockholders equity has grown by 2300.5% (from $8.46 million to $203.01 million).
- The most recent figure is from CRESCENT BIOPHARMA, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: